Rani Therapeutics Holdings, Inc. announced on January 2, 2022, upon the recommendation of its Nominating and Corporate Governance Committee, the board of directors (the Board) of company elected Lisa Rometty as a director of the Company, effective January 3, 2022, with a term expiring at the Company's next annual meeting of stockholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 USD | -6.15% | +8.43% | +97.59% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+97.59% | 184M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- RANI Stock
- News Rani Therapeutics Holdings, Inc.
- Rani Therapeutics Holdings, Inc. Announces Appointment of Lisa Rometty as Director